Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 909 record(s)

Req # A-2024-000012

Adverse Drug Reactions (ADRs). Report numbers: 001067949, 001069982.

Organization: Health Canada

17 page(s)
April 2024

Req # A-2024-000017

Adverse Drug Reaction (ADR) for ACITRETIN. Report number: 1071472. ADRs for ANASTROZOLE. Report numbers: 983160, 990116. ADR for CIPROFLOX. Report number: 1032025. ADR for Clonidine. Report number: 981372. ADRs for EPLERENONE. Reports number: 1026516, 1043922. ADRs for HYDROXYCHLOROQUINE. Report numbers: 1024918, 1026702, 1037377.

Organization: Health Canada

70 page(s)
April 2024

Req # A-2024-000028

Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20. Report numbers: 000709470, 000720165.

Organization: Health Canada

29 page(s)
April 2024

Req # A-2024-000032

Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.

Organization: Health Canada

76 page(s)
April 2024

Req # A-2024-000068

Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.

Organization: Health Canada

3 page(s)
April 2024

Req # A-2024-00001

All records about the Alpha House Society Calgary Housing Hub

Organization: Prairies Economic Development Canada

0 page(s)
April 2024

Req # A-2018-001052

All Electronic documents that pertain to Essure Permanent Birth Control System.

Organization: Health Canada

2286 page(s)
November 2023

Req # A-2020-000373

All briefing notes and related materials given to Minister Hajdu related to the coronavirus, Covid 19 in May.

Organization: Health Canada

177 page(s)
November 2023

Req # A-2020-000554

Concerning your access to information statistical report for fiscal year 2018/19 https://www.canada.ca/content/dam/tbs-sct/documents/access-information-privacy/2018-19-ati-eng.csv, please provide: the file number; in relation to the item, the date of any request for clarification; in relation to the item, the date of any extension of time.

Organization: Health Canada

2656 page(s)
November 2023

Req # A-2020-000672

All records concerning the refusal of Chinese officials to ship the CanSino Biologics Ad5-nCoV vaccine to Canada and the abandonment of the testing program. Time period: May 1, 2020 to September 1, 2020.

Organization: Health Canada

60 page(s)
November 2023
Date modified: